Explore articles and analysis related to artificial intelligence in healthcare, including coverage of diagnostics, pharma, drug development, medical billing, and more.
Tute Genomics is part of a grand shift towards the leveraging of genetic information towards better health and better treatments. One of the "holy grails" of this transition from one to the other is the advent of
If getting funding was easy, it wouldn't be called "getting funding."
Prospero Biosciences CEO Jonathan Rodriguez came on for an interview at Emerj to talk about his company and technology, as well as to shed some light on the real world experiences that a Biotech founder will face.